Contact Us

Latest News

Perosphere and Daiichi Sankyo Enter into a Clinical Trial Agreement.
04/25/13
First Hepatocellular Carcinoma Patient Ph3 Tivantinib.
01/31/13
Top-Line Results in Phase 2 Trial in Tivantinib with Colorectal Cancer.
01/11/13

Stay Connected!

Sign up for free email updates with the latest news about Daiichi Sankyo Careers.

select

Contact Us

U.S. Corporate Headquarters
Daiichi Sankyo, Inc.
Two Hilton Court
Parsippany, NJ 07054
Main Line: 973 944 2600

Directions

Global Development
Daiichi Sankyo Pharma Development
399 Thornall Street
Edison, NJ 08837
Main Line: 732 590 5000

Directions

Corporate Responsibility
More
Corporate Responsibility

At Daiichi Sankyo, everything we do leads back to our ultimate goal of improving lives. We are passionate about making a profound impact on those around us.

Benefits and Compensation
Benefits and Compensation

We offer benefits that reflect our respect for you, your work, and your family life. Our compensation programs are competitive and reward top performance and dedication.

Company Culture
More
Company Culture

The foundation of our culture is based on our core values of innovation, integrity and accountability.